The July issue of Acta Physiologica contains a beautiful example of how experimental biology provides new insights into the important topic of oral reception and subsequent perception of fatty substances in mammals. In the paper “Fatty acid taste quality information via GPR40 and CD36 in the posterior tongue of mice,” Nagai and colleagues [1] skillfully performed surgical experiments, that, combined with additional behavioral tests shed new light on the circuitry of fatty acid signaling in the mouth. The paper contains observations that easily could have been missed if less attention would have been paid to details. The authors reach the tempting (and debatable) conclusion that long-chain fatty acids (LCFA), at least for mice, taste like sweet and/or umami tastants.
In an earlier paper by the same group, also published in Acta Physiologica [2], electrophysiological measurements on single chorda tympani nerve fibers coming from the anterior tongue were performed on wildtype mice and knockout mice that lack the G protein-coupled receptor GPR120, also known as free fatty acid receptor 4 (FFAR4). GPR120 is one of the proteins that have been identified about two decades ago [3, 4] to be involved in fatty acid tasting, together with other proteins, including the G protein-coupled receptor GPR40, also known as free fatty acid receptor 1 (FFAR1) and the LCFA transporter CD36 (“cluster of differentiation 36”) [see [5] for a review]. These three proteins have very diverse roles in different organs and tissues. Both GPR120 and GPR40 function in pancreatic insulin signaling, and act as the prime receptors in the gut-brain axis of fatty acid signaling that determine the long-term “wanting” of high energy nutrients like sugars and fat [6]. Those functions are but a few examples of many for GPR120 and GPR40. CD36, on the other hand, is the high affinity transporter needed to import the fuel into demanding tissues such as the cardiac muscle, a tissue that mainly relies on the mitochondrial oxidation of LCFA for energy generation. CD36 also has many other functions [3, 5].
Whether the taste of fat (by sensing of LCFA that result from oral lipase actions on triglycerides) should be considered as the sixth taste modality (next to sweet, bitter, umami, salt and sour) has long been debated, but much evidence from experimental biology pleads for it. The specific term “oleogustus” has been coined [7] to provide a word that is easily recognized as pertaining to the taste of oily or fatty substances without referring to other sensations of fat perception, like texture and viscosity. Indeed, humans are quite capable of tasting free fatty acids of different chain lengths. Short-chain fatty acids taste sour, medium-chain fatty acids are experienced as irritants, and LCFA taste differently than any of the other basic modalities. LCFA are described as unpalatable [
{"title":"Tongue in Cheek: A Sweet and/or Umami Taste for Fatty Acids","authors":"Feike R. van der Leij","doi":"10.1111/apha.70088","DOIUrl":"https://doi.org/10.1111/apha.70088","url":null,"abstract":"<p>The July issue of <i>Acta Physiologica</i> contains a beautiful example of how experimental biology provides new insights into the important topic of oral reception and subsequent perception of fatty substances in mammals. In the paper “Fatty acid taste quality information via GPR40 and CD36 in the posterior tongue of mice,” Nagai and colleagues [<span>1</span>] skillfully performed surgical experiments, that, combined with additional behavioral tests shed new light on the circuitry of fatty acid signaling in the mouth. The paper contains observations that easily could have been missed if less attention would have been paid to details. The authors reach the tempting (and debatable) conclusion that long-chain fatty acids (LCFA), at least for mice, taste like sweet and/or umami tastants.</p><p>In an earlier paper by the same group, also published in Acta Physiologica [<span>2</span>], electrophysiological measurements on single chorda tympani nerve fibers coming from the anterior tongue were performed on wildtype mice and knockout mice that lack the G protein-coupled receptor GPR120, also known as free fatty acid receptor 4 (FFAR4). GPR120 is one of the proteins that have been identified about two decades ago [<span>3, 4</span>] to be involved in fatty acid tasting, together with other proteins, including the G protein-coupled receptor GPR40, also known as free fatty acid receptor 1 (FFAR1) and the LCFA transporter CD36 (“cluster of differentiation 36”) [see [<span>5</span>] for a review]. These three proteins have very diverse roles in different organs and tissues. Both GPR120 and GPR40 function in pancreatic insulin signaling, and act as the prime receptors in the gut-brain axis of fatty acid signaling that determine the long-term “wanting” of high energy nutrients like sugars and fat [<span>6</span>]. Those functions are but a few examples of many for GPR120 and GPR40. CD36, on the other hand, is the high affinity transporter needed to import the fuel into demanding tissues such as the cardiac muscle, a tissue that mainly relies on the mitochondrial oxidation of LCFA for energy generation. CD36 also has many other functions [<span>3, 5</span>].</p><p>Whether the taste of fat (by sensing of LCFA that result from oral lipase actions on triglycerides) should be considered as the sixth taste modality (next to sweet, bitter, umami, salt and sour) has long been debated, but much evidence from experimental biology pleads for it. The specific term “oleogustus” has been coined [<span>7</span>] to provide a word that is easily recognized as pertaining to the taste of oily or fatty substances without referring to other sensations of fat perception, like texture and viscosity. Indeed, humans are quite capable of tasting free fatty acids of different chain lengths. Short-chain fatty acids taste sour, medium-chain fatty acids are experienced as irritants, and LCFA taste differently than any of the other basic modalities. LCFA are described as unpalatable [","PeriodicalId":107,"journal":{"name":"Acta Physiologica","volume":"241 9","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apha.70088","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144767337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p>The airway surface liquid (ASL), which lines the luminal surface of the lung, is a complex layer containing mucins that trap inhaled particles and a liquid layer that supports ciliary function, that also contains antimicrobial peptides, proteins, and metabolites generated by the epithelial cells, inflammatory cells, and the resident lung microbiota. Precise regulation of ASL composition protects the pulmonary tissue from the external environment and is critical for a healthy lung.</p><p>Much is known about the identity and function of the airway epithelial ion channels and transporters that contribute to the regulation of ASL volume and mucus clearance. Nucleotides and nucleosides in the ASL modify fluid volume through receptor-mediatedion transport mechanisms [<span>1</span>], while bacterial metabolites are sensed by taste receptors in the ciliated and chemosensory cells of the airway and initiate protective reflexes [<span>2</span>].</p><p>Intermediary metabolites of glucose, such as lactate and pyruvate, as well as short chain fatty acids, are often elevated in the ASL during disease, and can render the lung more susceptible to infection and/or inflammation [<span>3</span>]. The increased abundance of ASL metabolites is associated with changes in cellular synthesis and transport [<span>4</span>]. The production and secretion of L-lactate into the ASL increase during hyperglycaemia, in the presence of bacteria and inflammation [<span>5, 6</span>]. The role of the H<sup>+</sup>-coupled monocarboxylate transporters (e.g., SLC16A1, 7 and 3; MCT1, 2 and 4 respectively) in the secretion of such metabolites, including into the ASL, has been reported [<span>5, 7</span>]. But is this a one-way process? Are metabolites also removed from the ASL and if so, how? A recent editorial and manuscript in Acta Physiologica highlighted new views on the shuttling of lactate from cell to cell and tissue to tissue as a proposed energy source, supporting both its secretion and uptake [<span>8, 9</span>]. But until now, there has been little documented evidence for transporters that enable the uptake of metabolites across the lumen of the airway and could play a role in the regulation of ASL metabolite concentration.</p><p>A new manuscript in Acta Physiologica, by Guenquen et al. [<span>10</span>] has changed that. The authors found that the Na<sup>+</sup>-coupled monocarboxylate transporter SLC5A8 (SMCT1) was highly expressed in mouse trachea and in human bronchial epithelial cultures. SLC5A8 is a member of a family that also includes more well-known Na<sup>+</sup>-coupled glucose transporters, such as SLC5A1 (SGLT1). These transporters can utilize the Na<sup>+</sup> gradient established by the epithelial Na<sup>+</sup>/K<sup>+</sup>-ATPase to drive uptake into the cell in the absence of a substrate gradient. As highlighted by Guenquen and colleagues, SLC5A8 has previously attracted attention as a tumor suppressor in several tissues (including the lung) and has b
{"title":"The SLC58A Na+-Monocarboxylate Transporter—Can It Scavenge Lung Metabolites to Prevent Airway Infections?","authors":"Deborah Baines, Robert Tarran","doi":"10.1111/apha.70086","DOIUrl":"https://doi.org/10.1111/apha.70086","url":null,"abstract":"<p>The airway surface liquid (ASL), which lines the luminal surface of the lung, is a complex layer containing mucins that trap inhaled particles and a liquid layer that supports ciliary function, that also contains antimicrobial peptides, proteins, and metabolites generated by the epithelial cells, inflammatory cells, and the resident lung microbiota. Precise regulation of ASL composition protects the pulmonary tissue from the external environment and is critical for a healthy lung.</p><p>Much is known about the identity and function of the airway epithelial ion channels and transporters that contribute to the regulation of ASL volume and mucus clearance. Nucleotides and nucleosides in the ASL modify fluid volume through receptor-mediatedion transport mechanisms [<span>1</span>], while bacterial metabolites are sensed by taste receptors in the ciliated and chemosensory cells of the airway and initiate protective reflexes [<span>2</span>].</p><p>Intermediary metabolites of glucose, such as lactate and pyruvate, as well as short chain fatty acids, are often elevated in the ASL during disease, and can render the lung more susceptible to infection and/or inflammation [<span>3</span>]. The increased abundance of ASL metabolites is associated with changes in cellular synthesis and transport [<span>4</span>]. The production and secretion of L-lactate into the ASL increase during hyperglycaemia, in the presence of bacteria and inflammation [<span>5, 6</span>]. The role of the H<sup>+</sup>-coupled monocarboxylate transporters (e.g., SLC16A1, 7 and 3; MCT1, 2 and 4 respectively) in the secretion of such metabolites, including into the ASL, has been reported [<span>5, 7</span>]. But is this a one-way process? Are metabolites also removed from the ASL and if so, how? A recent editorial and manuscript in Acta Physiologica highlighted new views on the shuttling of lactate from cell to cell and tissue to tissue as a proposed energy source, supporting both its secretion and uptake [<span>8, 9</span>]. But until now, there has been little documented evidence for transporters that enable the uptake of metabolites across the lumen of the airway and could play a role in the regulation of ASL metabolite concentration.</p><p>A new manuscript in Acta Physiologica, by Guenquen et al. [<span>10</span>] has changed that. The authors found that the Na<sup>+</sup>-coupled monocarboxylate transporter SLC5A8 (SMCT1) was highly expressed in mouse trachea and in human bronchial epithelial cultures. SLC5A8 is a member of a family that also includes more well-known Na<sup>+</sup>-coupled glucose transporters, such as SLC5A1 (SGLT1). These transporters can utilize the Na<sup>+</sup> gradient established by the epithelial Na<sup>+</sup>/K<sup>+</sup>-ATPase to drive uptake into the cell in the absence of a substrate gradient. As highlighted by Guenquen and colleagues, SLC5A8 has previously attracted attention as a tumor suppressor in several tissues (including the lung) and has b","PeriodicalId":107,"journal":{"name":"Acta Physiologica","volume":"241 9","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apha.70086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144758568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}